Degenerative cervical disc disease is a primary clinical setting for this cage, used during anterior cervical discectomy and fusion, where a surgeon has selected titanium over PEEK for its direct bone-integration properties and this cage's larger footprint for the vertebral body anatomy involved in a given case. Procurement governance matters here as much as clinical fit: NHS spine units evaluating titanium cervical interbody options need this cage stocked reliably alongside matched anterior cervical plate components, which is where Medigear. Medigear UK's role as a stocking supplier matters to tender decisions and theatre list planning. uk's role as a stocking supplier matters to tender decisions and theatre list planning.
Larger vertebral body anatomy forms a second clinical setting, where this cage's 16.8mm by 13.8mm footprint may better suit the endplate dimensions involved than the smaller footprint confirmed on Cervical Titanium Cage-III. However, XC has not confirmed specific selection guidance, and this should be discussed with the surgical team.
Cervical myelopathy and radiculopathy represent a third clinical setting, where nerve root or spinal cord compression from degenerative or herniated disc material is addressed through discectomy, with this titanium cage restoring the resulting disc space and supporting fusion during recovery from the procedure and subsequent rehabilitation.
Revision anterior cervical surgery makes up a fourth clinical setting, where a surgeon may select a titanium cage as part of a revised construct, particularly where imaging suggests bone did not adequately integrate with a previous PEEK device at the operated level. Medigear.uk supports single or small-quantity ordering of this cage alongside the larger bulk distributor accounts it also serves, so a specialist clinic is not required to commit to trust-scale volumes to access it.
